umu.sePublications
Change search
ReferencesLink to record
Permanent link

Direct link
Anorexigenic and electrophysiological actions of novel ghrelin receptor (GHS-R1A) antagonists in rats
Umeå University, Faculty of Medicine, Department of Integrative Medical Biology (IMB), Physiology.
Show others and affiliations
2009 (English)In: European Journal of Pharmacology, ISSN 0014-2999, E-ISSN 1879-0712, Vol. 612, no 1-3, 167-173 p.Article in journal (Refereed) PublishedText
Abstract [en]

Here we provide the first pharmacological exploration of the impact of acute central nervous system exposure to three recently developed ghrelin receptor (GHS-R1A) ligands on food intake and on the electrical activity of the target cells for ghrelin in the hypothalamus. Central (i.c.v) injection of GHS-R1A antagonists to rats suppressed food intake induced by i.c.v ghrelin injection (1 mu g) in a dose-dependent manner with a total blockade at concentraions of 0.4 mu g and 8 mu g for JMV 3002 and JMV 2959 respectively. JMV 2810, a partial agonist, also suppressed ghrelin-induced food intake (range: 0.02-2 mu g). Moreover all three compounds reduced fasting-induced food intake in rats (i.e. the amount of food eaten during the first hour of food exposure after a 16 h fast). At the single cell level we also explored the effects of the compounds to suppress ghrelin (0.5 mu M)-induced changes in electrical activity of arcuate nucleus cells recorded extracellularly in a slice preparation. Preincubation followed by perfusion with the GHS-R1A ligands suppressed the responsiveness of arcuate cells to ghrelin. Thus, the recently developed GHS-R1A ligands (JMV 3002, 2959 and 2810) suppress ghrelin-induced and fasting-induced food intake at the level of the central nervous system. This appears to be mediated, at least in part, by a modulation of the activity of ghrelin-responsive arcuate nucleus cells. As the central ghrelin signalling system has emerged as an important pro-obesity target, it will be important to establish the efficacy of these GHS-R1A ligands to reduce fast mass in clincal studies.

Place, publisher, year, edition, pages
Elsevier, 2009. Vol. 612, no 1-3, 167-173 p.
Keyword [en]
Arcuate nucleus, Feeding, Food intake, Growth hormone secretagogue, Hypothalamus, Neuropeptide Y
National Category
Social and Clinical Pharmacy Pharmacology and Toxicology
Identifiers
URN: urn:nbn:se:umu:diva-115995DOI: 10.1016/j.ejphar.2009.03.066ISI: 000267150900024PubMedID: 19356720OAI: oai:DiVA.org:umu-115995DiVA: diva2:906842
Available from: 2016-02-25 Created: 2016-02-08 Last updated: 2016-02-25Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Haage, David
By organisation
Physiology
In the same journal
European Journal of Pharmacology
Social and Clinical PharmacyPharmacology and Toxicology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 47 hits
ReferencesLink to record
Permanent link

Direct link